YS Biopharma Co, Buy Hold or Sell Recommendation
| YSDelisted Stock | 0.48 0.03 5.88% |
Allowing for the 90-day total investment horizon and your above-average risk tolerance, our recommendation regarding YS Biopharma Co, is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell YS Biopharma Co, given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for YS Biopharma Co,, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Note, we conduct extensive research on individual companies such as YS Biopharma and provide practical buy, sell, or hold advice based on investors' constraints. YS Biopharma Co,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
YS Biopharma |
Execute YS Biopharma Buy or Sell Advice
The YS Biopharma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on YS Biopharma Co,. Macroaxis does not own or have any residual interests in YS Biopharma Co, or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute YS Biopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
YS Biopharma Trading Alerts and Improvement Suggestions
| YS Biopharma Co, is now traded under the symbol LSB. Please update your portfolios or report it if you believe this is an error. Report It! | |
| YS Biopharma Co, is not yet fully synchronised with the market data | |
| YS Biopharma Co, has some characteristics of a very speculative penny stock | |
| YS Biopharma Co, has a very high chance of going through financial distress in the upcoming years | |
| The company generated the yearly revenue of 687.2 M. Annual Net Loss to common stockholders was (145.48 M) with gross profit of 0. | |
| YS Biopharma generates negative cash flow from operations | |
| About 81.0% of the company outstanding shares are owned by insiders |
YS Biopharma current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. YS Biopharma analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. YS Biopharma analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
YS Biopharma Returns Distribution Density
The distribution of YS Biopharma's historical returns is an attempt to chart the uncertainty of YS Biopharma's future price movements. The chart of the probability distribution of YS Biopharma daily returns describes the distribution of returns around its average expected value. We use YS Biopharma Co, price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of YS Biopharma returns is essential to provide solid investment advice for YS Biopharma.
| Mean Return | -0.56 | Value At Risk | -10.53 | Potential Upside | 10.29 | Standard Deviation | 6.81 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of YS Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
YS Biopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as YS Biopharma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About YS Biopharma Buy or Sell Advice
When is the right time to buy or sell YS Biopharma Co,? Buying financial instruments such as YS Biopharma Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having YS Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alternative Energy Thematic Idea Now
Alternative Energy
Large and mid-size companies, ETFs and funds that are either investing or directly involved in providing energy derived from sources not connected to fossil fuels, do not consume natural resources, and do not harm the environment. This includes wind power, nuclear and solar energy, biofuel, ethanol, hydrogen and others alternative sources of energy. The Alternative Energy theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alternative Energy Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in YS Biopharma Stock
If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |